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OBJECTIVES: Naming deficit is a linguistic symptom that appears in the initial phase of Alzheimer’s disease, but
the types of naming errors and the ways in which this deficit changes over the course of the disease are unclear.
We analyzed the performance of patients with Alzheimer’s disease on naming tasks during the mild and
moderate phases and verified how this linguistic skill deteriorates over the course of the disease.
METHODS: A reduced version of the Boston Naming Test was administered to 30 patients with mild Alzheimer’s
disease, 30 patients with moderate Alzheimer’s disease and 30 healthy controls. Errors were classified as verbal
semantic paraphasia, verbal phonemic paraphasia, no response (pure anomia), circumlocution, unrelated verbal
paraphasia, visual errors or intrusion errors.
RESULTS: The patients with moderate Alzheimer’s disease had significantly fewer correct answers than did both
the control group and the group with mild Alzheimer’s disease. With regard to the pattern of errors, verbal
semantic paraphasia errors were the most frequent errors in all three groups. Additionally, as the disease
severity increased, there was an increase in the number of no-response errors (pure anomia). The group with
moderate Alzheimer’s disease demonstrated a greater incidence of visual errors and unrelated verbal
paraphasias compared with the other two groups and presented a more variable pattern of errors.
CONCLUSIONS: Performance on nominative tasks worsened as the disease progressed in terms of both the
quantity and the type of errors encountered. This result reflects impairment at different levels of linguistic
processing.
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’ INTRODUCTION
Dementias represent a group of diseases that affect a
growing number of people because of the aging of the
world’s population. Alzheimer’s disease (AD) is the most
common type of dementia (1), as it is responsible for 50% to
70% of the total number of dementia cases worldwide (2).
AD is a degenerative disease of the nervous system, and its
most common characteristic is progressive and constant
deterioration of cognitive function. Recently, new diagnostic
criteria for AD have been advanced by the National Institute
of Aging/Alzheimer’s Association (3). The most common
presentation of AD is the amnestic form. The first symptoms
are progressive loss of recent memory and the ability to learn
new facts, followed by impairment of other areas of
cognition, and particularly language impairment.
Although memory impairment is the most evident initial
symptom, changes in speech and language in amnestic AD
have been studied more thoroughly in recent decades and
have been investigated more attentively in clinical practice.
Studies have indicated that the language deficit is progres-
sive and affects all aspects of language (comprehension and
production of oral discourse, reading and writing) during all
stages of the disease (4,5).
Regarding language disorders, anomia is the most evident
linguistic symptom, beginning in the initial phase of the
disease (6). Several studies have been conducted on this
topic, but the types of naming errors that occur and the ways
in which the deficit changes over the course of the disease are
still controversial (7–12). Whereas certain authors relate the
deficit to the degradation of semantic memory (7), other
studies relate the problem to failures in access to the
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phonological form of a word (8,9) or problems in other
subsystems (10,11). However, most authors have not examined
errors in different stages of the disease. One exception is
Chenery’s study (12), which compared subjects at different
stages of AD and concluded that the nature of anomia in these
patients changes over the course of the disease.
Studying the nature of naming ability is extremely
important because anomia is correlated with a more rapid
progression of the illness (13) and a greater likelihood of
whole-brain atrophy (14). Moreover, recent studies have
shown positive therapeutic effects for lexical semantic
treatment in early AD (15). Therefore, providing a qualitative
and quantitative description of naming deficits is essential.
Hence, the aim of this study was to analyze the performance
of patients with AD on naming tasks during the mild and
moderate phases of the disease to verify how this linguistic skill
deteriorates over the course of the disease. The hypothesis of
this study was that the anomia in AD changes both
quantitatively and qualitatively and that the qualitative
changes demonstrate compromise of different stages of the
linguistic processing of naming over the disease course.
’ MATERIALS AND METHODS
Ethics
This cross-sectional, observational study was conducted at
the outpatient clinic of the Behavioral Neurology Division in
the Speech Pathology Department of São Paulo Federal
University. The study was approved by the local research
ethics committee (Protocol Number 0957/06). After the
participants received complete information about the study,
written informed consent was obtained from all enrolled
subjects.
Subjects
The sample was composed of 90 individuals, who were
split into an AD group (ADG) and a control group (CG). The
general inclusion criteria were as follows: age X60 years;
X4 years of education; no history of alcoholism or drug use;
no use of psychotropic medications, except for atypical
neuroleptics; and an absence of visual or auditory impair-
ment that might affect the outcomes of cognitive tests.
Sixty patients had AD (30 in the mild stage and 30 in the
moderate stage) according to the clinical criteria proposed by
the National Institute of Neurological and Communicative
Disorders and Stroke – Alzheimer’s Disease and Related
Disorders Association (NINCDS-ADRDA) Work Group (16).
The neurological assessment was performed by an AD
expert. All of the patients diagnosed using the criteria were
submitted to a complete neuropsychiatric evaluation fol-
lowed by a neuropsychological evaluation. Cognitive screen-
ing tests, a neuropsychological battery and a functional
assessment were used for patient selection and group
classification.
The Mini-Mental State Examination (MMSE) was used as a
screening tool (17). We used a Portuguese translation and
Portuguese scoring of the MMSE (18). Only the individuals
with an MMSE score greater than 12 who were undergoing
treatment for AD with a therapeutic dose of acetylcholines-
terase inhibitors (donepezil X5 mg, rivastigmine X9 mg or
galantamine X8 mg) were selected. The subjects were also
assigned a Clinical Dementia Rating (CDR) (19). The CDR
scores were 0.5 or 1 for mild dementia and 2 for moderate
dementia.
For neuropsychological evaluation, the patients were
assessed using the protocol established by the Consortium
to Establish a Registry for Alzheimer’s Disease (CERAD)
(20), which addresses attention, memory, evocation, recogni-
tion, language, praxias, gnosias, and abstract thinking using
the following tests: verbal fluency, naming, word list
memory, constructive praxis, word list evocation, word list
recognition, apraxia evocation, and the trail test.
A functional scale questionnaire, or the Disability Assess-
ment for Dementia (DAD) (21), which was adapted for the
Brazilian population, was also performed (22).
The CG consisted of 30 healthy elderly volunteers with no
neurological or psychiatric changes who were paired with
the AD patients according to age and education. To evaluate
general cognition, the MMSE was used as a screening tool,
with cut-off scores adapted to the subjects’ educational levels
(18): elementary (1 to 4 years of education)=25; 5 to 8 years of
education=26.5; 9 to 11 years of education=28; and highly
educated (more than 12 years)=29.
In addition to the MMSE and a brief medical/neurological
history, the family members or caregivers of the CG subjects
completed the DAD to identify cognitive disorders that
would preclude participation in this study. The results were
analyzed according to the criteria proposed by Carthery et al.
(22), with scores higher than 99.0 allowing inclusion.
The CG consisted of individuals who were accompanying
patients, family members, friends, or students to the Senior
Citizens’ Open University; they were recruited after receiv-
ing authorization from the institution.
Procedure
All of the participants completed the revised version of the
Boston Naming Test (RBNT). The instrument contains
20 picture cards from the original instrument, including
the 15 pictures used by the CERAD Neuropsychological
Battery (20), and five cards that represented low-frequency
words.
The pictures used in the CERAD set depicted a tree, a bed,
a whistle, a flower, a house, a boat, a toothbrush, a volcano,
a mask, a camel, a harmonica, an ice gripper, a net, a funnel,
and dominoes. The supplementary figures were a racket, a
snail, an escalator, a harp, and a pyramid.
The test was administered according to the instructions in
the original manual. After the presentation of each card, the
individual was asked to name the object. Up to 20 seconds
were allowed for the response. If the participant was unable
to do so or if the first answer given was ‘‘I don’t know’’ or
‘‘I don’t remember,’’ a semantic cue was given. If the
participant still had no answer after 20 seconds, a phonemic
cue was given (the initial sound of the word).
The responses obtained on the RBNT were classified
according to whether they were correct or incorrect. Errors
were categorized into the following groups:
- Verbal semantic paraphasia: substitution of another word
semantically related to the target word (sheets x pillow);
- Verbal phonemic paraphasia: substitutions, omissions or
additions of phonemes or syllables (funnel x tunnel);
- No response (pure anomia): absence of the name;
- Circumlocution: substitution of a word for a phrase
(mask x it is used to go to a party);
- Unrelated verbal paraphasia: substitution of one word for
another unrelated to it in form or content (camel x pen);
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- Visual: substitution of one word for another that
represents a figure that is visually similar to the one
presented on the card (pyramid x triangle);
- Intrusion: repetition of a word that was previously
mentioned but that has no relation to the figure.
The correct answers, the answers given after a semantic
cue, and the answers given after a phonemic cue were tallied
on the test application form. The errors were also counted
and analyzed. Error classification was derived from the most
common nomenclature used in the literature (23).
Statistical analysis
The answers provided by the groups of patients with mild
or moderate AD were compared with each other and with
the results obtained from the CG. The differences between
the means of continuous data were tested using parametric
tests and corresponding non-parametric tests. When similar
results were achieved with the two tests, the parametric
results were used; when there was a discrepancy, however,
the non-parametric results were used. Non-parametric tests
are often robust enough to handle a degree of deviation from
normality, with the advantage of providing useful confidence
intervals (CIs), given that our preference is to use parametric
tests whenever possible.
Student’s t test (t) was used for paired samples, and its
corresponding non-parametric test, or the Wilcoxon signed
rank test (Z), was used for two dependent samples. For three
or more independent samples, we used one-factor one-way
analysis of variance (ANOVA) (F) and the corresponding
non-parametric Friedman’s test. When the ANOVA showed
that differences were statistically significant, Bonferroni’s
multiple comparison test was conducted to identify the
specific differences. Spearman’s correlation coefficient (r)
was also used to evaluate the relationship between contin-
uous variables.
A probability (P) value less than 0.05 was considered
statistically significant, and all of the tests were two tailed.
The 95% CIs were calculated for the differences between
averages and for odds ratios (ORs). All of the calculations
were performed using Statistical Package for the Social
Sciences (SPSS) 11.5.1 statistical software for Windows.
’ RESULTS
General characteristics
The mean age was 74.2 years (SD±6.0) in the mild ADG,
74.4 years (SD±5.2) in the moderate ADG, and 73.1 years
(SD±6.5) in the CG. On average, the mild ADG had 7.6
(SD±5.1) years of education, the moderate ADG had 6.9
(SD±4.7) years, and the CG had 6.6 (SD±5.3) years. No
significant differences were found between the ADGs and
the CG with respect to age or years of schooling; thus, it was
possible to compare the performance of the groups.
The mean MMSE score was 25.4 (SD±1.6) in the mild
ADG, 19.8 (SD±2.9) in the moderate ADG, and 28.6
(SD±1.4) in the CG. With the groups paired by age and
education, the mean MMSE score notably decreased as the
disease progressed. The group with mild AD had lower
scores than the CG did according to the score expected for
each education level, and the moderate ADG had lower
scores than the mild ADG did.
Evaluation of naming ability - intergroup analysis
An analysis of the performance of the three groups on the
RBNT is shown in Table 1. We observed that the number of
errors increased with progression of the disease. The nature of
the errors also differed among the three groups studied
(Table 1). According to the ANOVA, there were significant
differences in the mean numbers of correct answers, unrelated
verbal paraphasias, and no-response errors (pure anomia)
among the three groups of subjects. To determine where these
differences occurred, we performed Bonferroni’s multiple
comparison test (Table 2). We noted that patients with moderate
AD had fewer correct answers and made more unrelated verbal
paraphasias than did the subjects with mild AD and the subjects
in the CG. With regard to no-response errors (pure anomia), a
significant difference was found only between the group of
patients with moderate AD and the control subjects.
Types of errors - intragroup analysis
To evaluate which types of errors were most prevalent in
each group of subjects, we performed Wilcoxon’s signed
rank test; the results are presented in Table 3. We noted that
in the CG, there were significantly more verbal semantic
paraphasias than all other types of errors analyzed. In the
mild ADG, there was a significantly greater number of verbal
semantic paraphasias than all other types of errors, except for
no-response errors (pure anomia), which occurred at a
similar rate. Additionally, significantly more no-response
errors (pure anomia) were observed compared with intru-
sion and verbal phonemic paraphasias. However, the pattern
of errors in the group of patients with moderate AD was
more varied, including a greater frequency of visual errors
and unrelated verbal paraphasias than in the other groups.
’ DISCUSSION
The analysis of the performance of all of the groups on the
RBNT (Table 1) showed that the number of errors increased
Table 1 – Descriptive analysis based on the mean measurements of naming abilities and the ANOVA results.
Naming abilities Mean (SD) ANOVA F p-value
CG (30) Mild AD (30) Moderate AD (30)
Correct answers 17.2 (2.2) 16.4 (2.3) 13.9 (3.9) 10.68 o0.001*
Verbal semantic paraphasia errors 1.7 (1.5) 1.6 (1.3) 2.1 (1.3) 1.33 0.270
Verbal phonemic paraphasia errors 0 (0.2) 0.1 (0.3) 0.0 (0.0) 1.33 0.364
Unrelated verbal paraphasia errors 0.2 (0.5) 0.4 (0.6) 1.0 (1.1) 8.34 o0.001*
No-response (pure anomia) errors 0.3 (0.7) 0.9 (1.3) 1.9 (2.5) 7.15 0.001*
Circumlocution errors 0.2 (0.6) 0.3 (0.5) 0.3 (0.8) 0.22 0.799
Visual errors 0.3 (0.5) 0.4 (0.6) 0.7 (0.9) 3.19 0.046
Intrusion errors 0.0 (0.0) 0.0 (0.0) 0.1 (0.4) 1.00 0.372
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with progression of the disease. The literature agrees that
individuals with AD perform worse on visual confrontation
naming tasks compared with healthy subjects (4,6,7), even
though healthy older people also have word-finding deficits
(24). Studies have also indicated that it is possible to identify
naming failures early, even in the mild phase of AD, and that
this impairment worsens in proportion to the degree of the
illness (25,26).
In addition to the increased number of errors, the most
important finding of our study is that the patterns of naming
errors observed in AD patients changed as the disease evolved.
It was possible to measure the quantitative and qualitative
changes using a revised version of the Boston Naming Test.
Although verbal semantic paraphasias and no-response errors
(pure anomia) were observed in all groups, the number of
no-response errors (pure anomia) increased as the disease
progressed, and there were significantly more unrelated verbal
paraphasias among the moderate AD patients. We also observed
that patients in the moderate stage showed a more variable
pattern of errors, including visual errors (Tables 2 and 3).
Several studies have shown naming difficulties in AD
patients, but research on the changing nature of the errors
over the course of the disease is less common. In this context,
Chenery et al. (12) found similar results. The authors
specifically used the Boston Naming Test (27) to assess
subjects with AD, who were divided into three groups
according to dementia severity: mild (n=8), moderate (n=7)
and moderately severe (n=8). The results showed that in the
milder stages, anomia is related to the inability of a patient to
access the phonological label for a particular word. Over the
course of the disease, the responses of severely affected
subjects reflect the increased compromise of core semantic
structures and processes. However, the authors discussed the
need for studies with larger samples and further empirical
validation.
Verbal semantic paraphasias and no-response errors (pure
anomia) may be more strongly related to failures in the
semantic system. Certain authors have hypothesized that
AD patients perform worse than healthy individuals do in
visual confrontation naming tasks because of a semantic
Table 3 – Comparisons between the types of errors according to the groups of subjects.
Comparison Controls Mild AD Moderate AD
Z p-value Z p-value Z p-value
Verbal phonemic paraphasia - Verbal semantic paraphasia 4.1 o0.001* 4.3 o0.001*  4.6 o0.001*
Unrelated verbal paraphasia - Verbal semantic paraphasia 3.9 o0.001* 3.9 o0.001*  3.3 0.001
No response (pure anomia) - Verbal semantic paraphasia 3.8 o0.001* 1.9 0.062  1.1 0.258
Circumlocution - Verbal semantic paraphasia 3.7 o0.001* 3.8 o0.001*  4.4 o0.001*
Visual error - Verbal semantic paraphasia 3.8 o0.001* 3.9 o0.001*  3.9 o0.001*
Intrusion - Verbal semantic paraphasia 4.1 o0.001* 4.3 o0.001*  4.6 o0.001*
Unrelated verbal paraphasia - Verbal phonemic paraphasia 1.9 0.059 2.2 0.029  3.8 o0.001*
No response (pure anomia) - Verbal phonemic paraphasia 2.3 0.020 3.1 0.002*  3.8 o0.001*
Circumlocution - Verbal phonemic paraphasia 1.9 0.063 2.5 0.011  2.3 0.024
Visual error - Verbal phonemic paraphasia 2.8 0.005 2.3 0.020  3.6 o0.001*
Intrusion - Verbal phonemic paraphasia 1.0 0.317 1.4 0.157  1.0 0.317
No response (pure anomia) - Unrelated verbal paraphasia 0.5 0.589 2.2 0.027  1.7 0.092
Circumlocution - Unrelated verbal paraphasia 0.3 0.773 0.2 0.816  2.5 0.011
Visual error - Unrelated verbal paraphasia 1.1 0.257 0.0 1.000  1.0 0.340
Intrusion - Unrelated verbal paraphasia 2.1 0.034 2.8 0.005  3.7 o0.001*
Circumlocution - No response (pure anomia) 0.3 0.729 2.2 0.027  2.8 0.005
Visual error - No response (pure anomia) 0.0 1.000 2.1 0.033  2.4 0.017
Intrusion - No response (pure anomia) 2.3 0.024 3.3 0.001*  3.6 o0.001*
Visual error - Circumlocution 0.8 0.414 0.3 0.796  1.6 0.107
Intrusion - Circumlocution 2.1 0.038 2.9 0.004  1.5 0.143
po0.002 was considered to indicate statistical significance according to Bonferroni’s correction; Z=Wilcoxon signed rank test; P=probability
Table 2 – Results of Bonferroni’s multiple comparison test for the mean numbers of correct answers, unrelated verbal
paraphasias, and no-response errors (pure anomia) for the different groups of subjects.
Comparison among the groups Difference in means 95% CI (difference) p-value
Correct responses
Controls x Mild AD 0.83  1.00 to 2.67 0.810
Controls x Moderate AD 3.33 1.50 to 5.17 o0.001*
Mild AD x Moderate AD 2.50 0.67 to 4.33 0.004*
Unrelated verbal paraphasias
Controls x Mild AD 0.17  0.67 to 0.34 1.000
Controls x Moderate AD 0.80  1.30 to  0.30 0.001*
Mild AD x Moderate AD 0.63  1.14 to  0.13 0.009*
No response (pure anomia)
Controls x Mild AD 0.63  1.67 to 0.41 0.422
Controls x Moderate AD 1.60  2.64 to  0.56 0.001*
Mild AD x Moderate AD 0.97  2.01 to 0.07 0.077
CI = confidence interval
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breakdown caused by store degradation (7). Performance
impairment results as neurodegeneration spreads to the
association cortices that presumably store semantic repre-
sentations (28). However, semantic errors do not system-
atically reflect only a deficit of semantic knowledge in AD
patients; instead, they reveal a deficit in retrieval of the
phonological form and a deficit in accessing semantic
knowledge in the visual modality (8). Verbal semantic
paraphasias in early phases of AD could reflect a breakdown
in access to phonological representations of object names as a
consequence of reduced inhibitory control over other highly
active alternatives (9), whereas the increase in no-response
errors (pure anomia) in moderate AD is possibly related to a
loss of semantic information.
In our study, we observed that errors of a visual nature
also gradually increased with the course of the disease; in
particular, these errors were more prevalent in the group
with moderate AD. Because the naming task was carried out
using visual confrontation, it is important to remember that
naming alterations could exist because of a failure in the
visual object recognition system or a failure to access the
semantic system because of the visual processing require-
ment. However, our results showed that even receiving
phonemic and semantic cues did not interfere with the
results. Thus, in this case, naming problems stemmed from
deterioration of the detailed conceptual knowledge of an
item and should not be attributed only to a specific deficit of
semantic processing. Nevertheless, as the illness progresses,
perception problems, including visual agnosia, also contri-
bute to patients’ naming difficulties (10,11) in visual
confrontation naming tasks because visual perception other-
wise helps patients to identify an item.
In addition to a greater number of visual errors in the
group with moderate AD compared with the subjects with
mild AD and the CG, the results indicated an increase in
unrelated verbal paraphasias and a more varied pattern of
errors in general. These results seem to reflect the impair-
ment of several linguistic subsystems, with alterations at
different levels of linguistic processing, in addition to the
increase in cognitive modifications in general (such as visual
perception), resulting from the involvement of various
cerebral areas and consequently leading to greater linguis-
tic-cognitive compromise.
The fact that the temporal lobe becomes more involved as
AD advances may explain the deficit in word retrieval (29).
However, it is necessary to consider more recent studies that
have suggested the involvement of more anterior and ventral
frontal portions, and especially the inferior frontal gyrus (30).
Left lateral temporal atrophy and other distinct neuroanato-
mical signs of AD are consistent with the hypothesis that a
large-scale neural network supports naming (31). We should
expect, however, that more linguistic and cognitive systems
will be affected as the disease progresses and as cortical areas
are damaged. Therefore, semantic processing involves
extensive areas of brain function, and no-response errors
(pure anomia) may be attributable to lesions on multiple
areas of the brain that are involved in diverse processes.
Longitudinal studies have shown that the most severe
naming deficits increase from mild to moderate dementia.
The possible causes are lexical-semantic and visual-
perceptive dysfunctions (13), and the appearance of visuos-
patial and constructional impairment is most likely due to
increasing pathological involvement of the posterior associa-
tion cortex. The ability to visually discriminate nameable
objects in AD also strongly predicts patients’ performance in
both picture naming and semantic association (32).
In sum, in analyzing the errors found in this study, we
noted a quantitative difference in the errors made by the
three groups. Similarly, in addition to the increase in
the number of errors as the disease progressed, we noted
that the types of errors (which also differed qualitatively)
might differentiate healthy subjects from patients with
various stages of AD. This result seems to reflect impairment
at different levels of linguistic processing and suggests that
the underlying basis of the anomia changes as the disease
progresses. Identifying the types of naming errors in AD is
essential for the appropriate implementation of therapeutic
strategies for these patients. In addition, qualitative analysis
of naming errors in AD is an important tool to help with
differentially diagnosing AD and other forms of dementia.
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and progression of Alzheimeŕs disease: an analysis of error types. Neu-
ropsychologia. 1998;36(5):397–405, http://dx.doi.org/10.1016/S0028-
3932(97)00124-3.
26. Thompson-Schill SL, Gabrieli JD, Fleischman DA. Effects of structural
similarity and naming frequency on picture naming in Alzheimeŕs dis-
ease. J Int Neuropsychol Soc. 1999;5(7):659–67.
27. Kaplan E, Goodglass H, Weintraub S. The Boston naming test. Philadel-
phia: Lea & Febiger, 1983.
28. Salmon DP, Butters N, Chan AS. The deterioration of semantic memory in
Alzheimer’s disease. Can J Exp Psychol. 1999;53(1):108–17, http://dx.doi.
org/10.1037/h0087303.
29. Domoto-Reilly K, Sapolsky D, Brickhouse M, Dickerson BC. Naming
impairment in Alzheimer’s disease is associated with left anterior tem-
poral lobe atrophy. Neuroimage. 2012;63(1):348–55, http://dx.doi.org/
10.1016/j.neuroimage.2012.06.018.
30. Melrose RJ, Campa OM, Harwood DG, Osato S, Mandelkern MA, Sultzer
DL. The neural correlates of naming and fluency deficits in Alzheimer’s
disease: an FDG-PET study. Int J Geriatr Psychiatry. 2009;24(8):885–93,
http://dx.doi.org/10.1002/gps.v24:8.
31. Grossman M, McMillan C, Moore P, Ding L, Glosser G, Work M, et al.
What’s in a name: voxel-based morphometric analyses of MRI and
naming difficulty in Alzheimer’s disease, frontotemporal dementia and
corticobasal degeneration. Brain. 2004;127(Pt3):628–49, http://dx.doi.
org/10.1093/brain/awh075.
32. Harnish SM, Neils-Strunjas J, Eliassen J, Reilly J, Meinzer M, Clark JG,
et al. Visual discrimination predicts naming and semantic association
accuracy in Alzheimer disease. Cogn Behav Neurol. 2010;23(4):231–9,
http://dx.doi.org/10.1097/WNN.0b013e3181e61cf1.
428
Naming Changes in Alzheimer’s Disease
Silagi ML et al.
CLINICS 2015;70(6):423-428
